(USD) | Mar 2024 | Q/Q |
---|---|---|
Revenue | 12.3B | -14% |
Gross Profit | 8.2B | - |
Cost Of Revenue | 4.1B | -28% |
Operating Income | 2.8B | -12% |
Operating Expenses | 5.4B | - |
Net Income | 1.4B | +67% |
R&D | 1.9B | +1% |
G&A | 3.3B | +4% |
Amortization | 1.9B | -0% |
Interest Expense | 660MM | +17% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In this piece, we will take a look at the top 25 stocks in the S&P 500 by index weight right now. If you want to skip our coverage of the flagship stock index and some recent news for its biggest constituents then you can skip ahead to Top 10 Stocks in the S&P 500 […]
From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.
CVS warns it could cede Medicare Advantage market share as reimbursement rates pressure the company.
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.